Quick answer
What is the chemical structure of AOD-9604? AOD-9604 is a 16-residue linear peptide, Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe, with the molecular formula C78H123N23O23S2. It corresponds to the C-terminal region of human growth hormone (labeled 176–191), with an added tyrosine at the N-terminus and a single disulfide bond joining the two cysteines at positions 7 and 14 of the peptide. That bond closes a small ring and is the structural feature that most affects how the peptide is handled, analyzed and stored in the laboratory.
This article reads the AOD-9604 sequence residue by residue: what each part of the chain is, where it comes from in the parent hormone, and which analytical checks confirm that a vial contains the intended molecule. It is a structure-focused companion to the AOD-9604 research overview. For laboratory research use only; not for human consumption.
The sequence, position by position
Numbered from the N-terminus, the peptide contains sixteen amino acids. The V8 AOD-9604 product page gives the sequence as Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe and the formula as C78H123N23O23S2, supplied as a 5 mg lyophilized powder with a ≥98% purity specification.
| Position | Residue | Side-chain class | Note for the analyst |
|---|---|---|---|
| 1 | Tyr | Aromatic, polar | Absorbs near 275 nm; the N-terminal Tyr is the UV handle for concentration checks |
| 2 | Leu | Hydrophobic | Contributes to retention on reversed-phase columns |
| 3 | Arg | Basic | Positive charge at neutral pH |
| 4–5 | Ile, Val | Hydrophobic | Beta-branched, bulky |
| 6 | Gln | Polar, uncharged | Amide side chain |
| 7 | Cys | Thiol | First half of the disulfide bridge |
| 8 | Arg | Basic | Second positive charge |
| 9 | Ser | Polar | Hydroxyl side chain |
| 10 | Val | Hydrophobic | |
| 11 | Glu | Acidic | Negative charge at neutral pH |
| 12 | Gly | None | Flexible hinge inside the ring |
| 13 | Ser | Polar | |
| 14 | Cys | Thiol | Second half of the disulfide bridge |
| 15 | Gly | None | Outside the ring |
| 16 | Phe | Aromatic, hydrophobic | C-terminal residue |
Two arginines, one glutamate and no lysine or histidine give the peptide a net positive charge at neutral pH, which affects how it behaves in ion-pairing chromatography and in buffers of different ionic strength. A general introduction to reading such strings is in understanding amino acid sequences.
Where the chain comes from: the hGH 176–191 region
Human growth hormone is a 191-residue protein. AOD-9604 reproduces the extreme C-terminal stretch, in which the native chain forms a disulfide-closed loop. The synthetic peptide carries an added tyrosine at the N-terminus, and the whole 16-residue molecule is the one labeled 176–191 on the product page. The usual explanation in the literature is that the added aromatic residue provides a convenient site for labeling and spectroscopic quantification without altering the loop. Early metabolic work on the fragment, described by Ng and colleagues (2000) and by Heffernan and colleagues (2001), used rodent models to compare the fragment with the full hormone; those studies are discussed in the AOD-9604 versus HGH fragment 176-191 comparison.
The distinction matters for sourcing and labeling. A vial described only as "hGH 176-191" and a vial described as "AOD-9604" may differ by that one tyrosine, so the sequence and the molecular formula, not the name, should be the identity reference in the lab notebook.
The disulfide bridge and the ring it forms
Cysteines 7 and 14 form an intramolecular disulfide, leaving a ring of eight residues (positions 7–14) with a short, open tail at each end. Three practical consequences follow:
- Redox sensitivity. Reducing agents such as dithiothreitol or tris(2-carboxyethyl)phosphine open the ring; the peptide then has a different mass (two hydrogens heavier) and a different chromatographic retention time.
- Scrambling risk. Under alkaline conditions, free thiols can attack the disulfide and exchange partners, producing intermolecular dimers or oligomers. The chemistry of thiols and disulfides in peptide stability is reviewed by Trivedi and colleagues (2009).
- Oxidation of other residues. The sequence contains no methionine or tryptophan, so the common oxidation sites are limited to the cysteines and the tyrosine.
Handling advice that follows from the structure is collected in AOD-9604 peptide explained; solvent choices are covered in how to reconstitute a lyophilized peptide.
Mass and formula as an identity check
The formula C78H123N23O23S2 corresponds to an average molecular mass of roughly 1.8 kDa. Because a disulfide-bonded and a reduced chain differ by two hydrogens, a mass measurement can distinguish the intended ring-closed form from the open form. The table summarizes which analytical question each common technique answers for this molecule.
| Technique | Question answered | Limit |
|---|---|---|
| Reversed-phase HPLC | What fraction of the UV signal is the main peak | Does not prove identity or net peptide content |
| Intact-mass measurement | Does the mass match the formula, closed or open ring | Needs a method able to resolve a 2 Da shift |
| Amino-acid analysis | Is the composition as expected, and how much peptide is present | Destroys the sample; cysteine needs special handling |
| Ellman-type thiol assay | Are free thiols present, indicating open rings | Low sensitivity at small quantities |
The V8 product page lists identity and purity checks and a lot-level certificate where one is published; see understanding HPLC purity, HPLC versus mass spectrometry and AOD-9604 purity testing for how to read those documents. The quality-specification principles for synthetic peptides in general are laid out by Vergote and colleagues (2009).
Synthesis and the impurities the structure predicts
Chains of this length are made by solid-phase synthesis, with the two cysteines oxidized to form the ring after cleavage. Knowing the sequence lets an analyst predict the most likely impurities:
- Deletion sequences, where a residue failed to couple, most likely around the bulky Ile-Val pair at positions 4–5.
- Dimers, where two chains formed intermolecular rather than intramolecular disulfides during oxidation.
- Reduced or partially oxidized forms, from incomplete ring closure.
- Deamidation products at Gln6, a slower reaction than Asn deamidation but one covered in the peptide-degradation literature (Geiger and Clarke, 1987).
Each of these has a distinct retention time or mass, which is why a single "98%" figure is the start of an analysis rather than the end of one.
Numbering conventions that cause confusion
Three numbering schemes appear in the literature, and mixing them up is a common source of error when comparing papers. The first is the parent-protein numbering, in which the fragment is "176–191" because it occupies those positions in the 191-residue hormone. The second is the fragment's own numbering, in which the tyrosine is residue 1 and the cysteines are residues 7 and 14. The third is the shorthand "177–191" found in some early reports, which counts the fifteen native residues and leaves the extra tyrosine out. When a paper says a modification was made "at Cys182," that is parent numbering; the same atom is Cys7 in the fragment. A short conversion line in the lab notebook, stating which scheme a given source uses, prevents mis-assigned mass-spectral fragments and mis-labeled mutants.
A related point concerns the termini. The N-terminus carries a free amine and the C-terminus a free carboxylate in the standard form, so the molecule is a zwitterion in the pH range where most experiments run. Capped variants, acetylated or amidated, have different masses and charges and should not be assumed to be interchangeable with the free form.
Reading a certificate against this structure
When a lot certificate is published, three entries are worth checking against the structure on this page. The first is the stated formula or mass, which should match C78H123N23O23S2 or its average mass of about 1.8 kDa. The second is the chromatographic purity figure and the conditions behind it: column, gradient, detection wavelength and whether the main peak was integrated with or without shoulders. The third is the test date and lot number, which tie the document to the vial in hand. Where no certificate is listed for a lot, record that fact rather than inferring one.
Using the structure in experimental planning
When planning a bench experiment, write the identity data into the protocol before the first vial is opened: sequence, formula, ring status, lot number and storage condition. The V8 product page lists refrigeration at 2–8 °C and −20 °C for long-term storage, protected from heat, moisture and light. Concentration arithmetic is a formula, mass of peptide divided by final solution volume, and the reconstitution calculator performs it; the COA library shows which lot documents are published. Related background is in the pillar overview and the full catalog.
Frequently asked questions
How many amino acids are in AOD-9604?
Sixteen. The sequence is Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe, matching the sequence listed on the V8 product page.
What is the molecular formula of AOD-9604?
C78H123N23O23S2, as listed on the product page. The two sulfur atoms belong to the two cysteine residues.
Where does the sequence come from?
It reproduces the C-terminal region of human growth hormone, residues 176–191, with a tyrosine added at the N-terminus.
Why is the disulfide bond important?
It joins cysteines 7 and 14 into a ring. Reducing agents or alkaline buffers can open or rearrange it, changing the mass and the retention time of the peptide.
Why is a tyrosine added at the N-terminus?
The published explanation is that the aromatic residue provides a handle for labeling and UV quantification without changing the C-terminal loop.
Does the sequence contain residues that oxidize easily?
It has no methionine or tryptophan. The main oxidation-prone positions are the two cysteines and the tyrosine.
What net charge does the peptide carry at neutral pH?
It carries two arginines and one glutamate and no lysine or histidine, so it is net positive at neutral pH, which influences chromatography and buffer selection.
Can HPLC alone confirm that the vial contains AOD-9604?
No. HPLC reports the purity of the main peak, not its identity. An intact-mass measurement or amino-acid analysis is needed to match the molecule to the formula.
Why do papers disagree on whether the fragment is 176-191 or 177-191?
The two labels count the same native stretch differently. The 177-191 label refers to the fifteen native residues; the 176-191 label, used on the V8 product page, includes the added N-terminal tyrosine as a sixteenth position.
What should be recorded in the notebook before opening a vial?
Record the sequence, formula, ring status, lot number, storage condition and the numbering scheme used by each source, so results from different papers can be compared without guessing which residue is meant.
How does V8 supply AOD-9604?
As a 5 mg lyophilized powder in a sealed clear glass research vial, with a ≥98% purity specification, for laboratory research use only.
Related reading: AOD-9604 Compatibility and Combination Study Design, AOD-9604 vs Retatrutide: Fragment or Triple Agonist?, AOD-9604: Fragment Design and Lipolysis Research.
References
- Ng FM, et al. Metabolic studies of a synthetic lipolytic domain (AOD9604) of human growth hormone. Horm Res. 2000;53(6):274-278. doi:10.1159/000053183
- Heffernan M, et al. Increase of fat oxidation and weight loss in obese mice caused by chronic treatment with human growth hormone or a modified C-terminal fragment. Int J Obes Relat Metab Disord. 2001;25(10):1442-1449. doi:10.1038/sj.ijo.0801740
- Trivedi MV, Laurence JS, Siahaan TJ. The role of thiols and disulfides on protein stability. Curr Protein Pept Sci. 2009;10(6):614-625. doi:10.2174/138920309789630534
- Vergote V, Burvenich C, Van de Wiele C, De Spiegeleer B. Quality specifications for peptide drugs: a regulatory-pharmaceutical approach. J Pept Sci. 2009;15(11):697-710. doi:10.1002/psc.1167
- Geiger T, Clarke S. Deamidation, isomerization, and racemization at asparaginyl and aspartyl residues in peptides. Succinimide-linked reactions that contribute to protein degradation. J Biol Chem. 1987;262(2):785-794. PMID: 3805008
